PerkinElmer, Inc.  

(Public, NYSE:PKI)   Watch this stock  
Find more results for Absorption Spectrum
50.42
-0.42 (-0.83%)
Apr 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 49.77 - 50.53
52 week 39.50 - 54.52
Open 50.46
Vol / Avg. 503,415.00/536,764.00
Mkt cap 5.44B
P/E 26.85
Div/yield 0.07/0.56
EPS 1.88
Shares 109.79M
Beta 1.02
Inst. own 96%
May 11, 2016
PerkinElmer Inc at Bank of America Merrill Lynch Health Care Conference - 5:20PM EDT - Add to calendar
May 5, 2016
Q1 2016 PerkinElmer Inc Earnings Call - 5:00PM EDT - Add to calendar
May 5, 2016
Q1 2016 PerkinElmer Inc Earnings Release - 4:00PM EDT - Add to calendar
Apr 27, 2016
PerkinElmer Inc Annual Shareholders Meeting (Estimated)
Apr 26, 2016
PerkinElmer Inc Annual Shareholders Meeting
Mar 7, 2016
PerkinElmer Inc at Cowen Health Care Conference
Feb 4, 2016
Q4 2015 PerkinElmer Inc Earnings Call
Feb 4, 2016
Q4 2015 PerkinElmer Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '16) 2016
Net profit margin 11.26% 9.40%
Operating margin 13.93% 12.65%
EBITD margin - 18.20%
Return on average assets 6.70% 5.13%
Return on average equity 13.19% 10.24%
Employees 8,000 -
CDP Score - 61 E

Address

940 Winter St
WALTHAM, MA 02451-1457
United States - Map
+1-781-6635776 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company's operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier. Within its Human Health segment, the Company serves the diagnostics and research markets. It provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market. The Environmental Health segment provides products, services and solutions to facilitate the creation of safer food and consumer products, secure surroundings and energy resources. The Environmental Health segment serves the environmental, industrial and laboratory services markets. The Company markets its products and services in over 150 countries.

Officers and directors

Robert F. Friel Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank Anders Wilson CPA Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Joel S. Goldberg Senior Vice President, Administration, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
James L. Corbett Senior Vice President and President-Human Health
Age: 53
Bio & Compensation  - Reuters
Jon P. DiVincenzo Senior Vice President, President - Environmental Health
Age: 49
Bio & Compensation  - Reuters
Daniel Tereau Senior Vice President, Strategy and Business Development
Age: 49
Bio & Compensation  - Reuters
Andrew Okun Chief Accounting Officer, Vice President
Age: 46
Bio & Compensation  - Reuters
Alexis P. Michas Lead Independent Director
Age: 58
Bio & Compensation  - Reuters
Peter Barrett Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Sylvie L. Gregoire Independent Director
Age: 54
Bio & Compensation  - Reuters